Stryker Gross Profit Growth & History (SYK)
Stryker's gross profit was $16.07B for fiscal 2025.
View full Stryker company overviewStryker annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $16.07B | $1.63B | +11.25% |
| 2024 | 2024-12-31 | $14.44B | $1.38B | +10.58% |
| 2023 | 2023-12-31 | $13.06B | $1.48B | +12.78% |
| 2022 | 2022-12-31 | $11.58B | $610.0M | +5.56% |
| 2021 | 2021-12-31 | $10.97B | $1.91B | +21.10% |
| 2020 | 2020-12-31 | $9.06B | −$639.0M | −6.59% |
| 2019 | 2019-12-31 | $9.70B | $758.0M | +8.48% |
| 2018 | 2018-12-31 | $8.94B | $758.0M | +9.27% |
| 2017 | 2017-12-31 | $8.18B | $676.0M | +9.01% |
| 2016 | 2016-12-31 | $7.50B | $902.0M | +13.66% |
| 2015 | 2015-12-31 | $6.60B | $246.0M | +3.87% |
| 2014 | 2014-12-31 | $6.36B | $337.0M | +5.60% |
| 2013 | 2013-12-31 | $6.02B | $143.0M | +2.43% |
| 2012 | 2012-12-31 | $5.88B | $380.0M | +6.91% |
| 2011 | 2011-12-31 | $5.50B | $462.0M | +9.18% |
| 2010 | 2010-12-31 | $5.03B | $495.0M | +10.91% |
| 2009 | 2009-12-31 | $4.54B | −$47.8M | −1.04% |
| 2008 | 2008-12-31 | $4.59B | $451.5M | +10.92% |
| 2007 | 2007-12-31 | $4.14B | — | — |
Stryker quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.50B | $657.0M | +17.10% |
| Q1 2026 | 2026-03-31 | $3.81B | $66.0M | +1.76% |
| Q4 2025 | 2025-12-31 | $4.63B | $454.0M | +10.88% |
| Q3 2025 | 2025-09-30 | $3.85B | $335.0M | +9.53% |
| Q2 2025 | 2025-06-30 | $3.84B | $425.0M | +12.44% |
| Q1 2025 | 2025-03-31 | $3.74B | $411.0M | +12.33% |
| Q4 2024 | 2024-12-31 | $4.17B | $471.0M | +12.72% |
| Q3 2024 | 2024-09-30 | $3.52B | $359.0M | +11.37% |
| Q2 2024 | 2024-06-30 | $3.42B | $235.0M | +7.39% |
| Q1 2024 | 2024-03-31 | $3.33B | $317.0M | +10.51% |
| Q4 2023 | 2023-12-31 | $3.70B | $467.0M | +14.43% |
| Q3 2023 | 2023-09-30 | $3.16B | $376.0M | +13.52% |
| Q2 2023 | 2023-06-30 | $3.18B | $355.0M | +12.56% |
| Q1 2023 | 2023-03-31 | $3.02B | $282.0M | +10.31% |
| Q4 2022 | 2022-12-31 | $3.24B | $191.0M | +6.27% |
| Q3 2022 | 2022-09-30 | $2.78B | $140.0M | +5.30% |
| Q2 2022 | 2022-06-30 | $2.83B | $54.0M | +1.95% |
| Q1 2022 | 2022-03-31 | $2.73B | $225.0M | +8.97% |
| Q4 2021 | 2021-12-31 | $3.04B | $328.0M | +12.07% |
| Q3 2021 | 2021-09-30 | $2.64B | $181.0M | +7.35% |
| Q2 2021 | 2021-06-30 | $2.77B | $1.22B | +79.07% |
| Q1 2021 | 2021-03-31 | $2.51B | $178.0M | +7.64% |
| Q4 2020 | 2020-12-31 | $2.72B | $14.0M | +0.52% |
| Q3 2020 | 2020-09-30 | $2.46B | $131.0M | +5.62% |
| Q2 2020 | 2020-06-30 | $1.55B | −$832.0M | −34.96% |
| Q1 2020 | 2020-03-31 | $2.33B | $48.0M | +2.10% |
| Q4 2019 | 2019-12-31 | $2.70B | $247.0M | +10.06% |
| Q3 2019 | 2019-09-30 | $2.33B | $175.0M | +8.12% |
| Q2 2019 | 2019-06-30 | $2.38B | $190.0M | +8.68% |
| Q1 2019 | 2019-03-31 | $2.28B | $146.0M | +6.83% |
| Q4 2018 | 2018-12-31 | $2.46B | $215.0M | +9.59% |
| Q3 2018 | 2018-09-30 | $2.15B | $171.0M | +8.62% |
| Q2 2018 | 2018-06-30 | $2.19B | $199.0M | +9.99% |
| Q1 2018 | 2018-03-31 | $2.14B | $173.0M | +8.81% |
| Q4 2017 | 2017-12-31 | $2.24B | $155.0M | +7.43% |
| Q3 2017 | 2017-09-30 | $1.98B | $111.0M | +5.93% |
| Q2 2017 | 2017-06-30 | $1.99B | $149.0M | +8.09% |
| Q1 2017 | 2017-03-31 | $1.96B | $270.0M | +15.94% |
| Q4 2016 | 2016-12-31 | $2.09B | $266.0M | +14.62% |
| Q3 2016 | 2016-09-30 | $1.87B | $249.0M | +15.33% |
| Q2 2016 | 2016-06-30 | $1.84B | $237.0M | +14.77% |
| Q1 2016 | 2016-03-31 | $1.69B | $141.0M | +9.08% |
| Q4 2015 | 2015-12-31 | $1.82B | $102.0M | +5.94% |
| Q3 2015 | 2015-09-30 | $1.62B | $64.0M | +4.10% |
| Q2 2015 | 2015-06-30 | $1.60B | $57.0M | +3.68% |
| Q1 2015 | 2015-03-31 | $1.55B | $24.0M | +1.57% |
| Q4 2014 | 2014-12-31 | $1.72B | $102.0M | +6.31% |
| Q3 2014 | 2014-09-30 | $1.56B | $91.0M | +6.19% |
| Q2 2014 | 2014-06-30 | $1.55B | $66.0M | +4.45% |
| Q1 2014 | 2014-03-31 | $1.53B | $52.0M | +3.52% |
| Q4 2013 | 2013-12-31 | $1.62B | $23.0M | +1.44% |
| Q3 2013 | 2013-09-30 | $1.47B | $72.0M | +5.15% |
| Q2 2013 | 2013-06-30 | $1.48B | $48.0M | +3.35% |
| Q1 2013 | 2013-03-31 | $1.48B | $25.0M | +1.72% |
| Q4 2012 | 2012-12-31 | $1.59B | $118.0M | +8.00% |
| Q3 2012 | 2012-09-30 | $1.40B | $35.0M | +2.57% |
| Q2 2012 | 2012-06-30 | $1.43B | $101.0M | +7.58% |
| Q1 2012 | 2012-03-31 | $1.45B | $126.0M | +9.50% |
| Q4 2011 | 2011-12-31 | $1.48B | $104.0M | +7.59% |
| Q3 2011 | 2011-09-30 | $1.36B | $135.0M | +11.00% |
| Q2 2011 | 2011-06-30 | $1.33B | $114.0M | +9.35% |
| Q1 2011 | 2011-03-31 | $1.33B | $109.0M | +8.96% |
| Q4 2010 | 2010-12-31 | $1.37B | $130.0M | +10.48% |
| Q3 2010 | 2010-09-30 | $1.23B | $112.4M | +10.08% |
| Q2 2010 | 2010-06-30 | $1.22B | $121.0M | +11.02% |
| Q1 2010 | 2010-03-31 | $1.22B | $131.2M | +12.08% |
| Q4 2009 | 2009-12-31 | $1.24B | — | — |
| Q3 2009 | 2009-09-30 | $1.11B | $3.3M | +0.30% |
| Q2 2009 | 2009-06-30 | $1.10B | −$81.4M | −6.90% |
| Q1 2009 | 2009-03-31 | $1.09B | — | — |
| Q3 2008 | 2008-09-30 | $1.11B | — | — |
| Q2 2008 | 2008-06-30 | $1.18B | — | — |
Stryker gross profit trends
Over the last five fiscal years, Stryker's gross profit increased from $9.06B to $16.07B, a change of $7.01B. The latest reported quarter, Q2 2026, shows $4.50B.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Stryker source filings ↗Community posts
Stryker completes ZuriMED acquisition to broaden its shoulder-repair offering
Stryker ($SYK) completed its acquisition of privately held ZuriMED, adding FiberLocker technology to its sports medicine business. The commercialized product is used to augment rotator cuff repair and is designed to increase the mechanical ...